Diabetes (Pediatric)

Gruppo San Donato is at the forefront of the diagnosis, treatment, and prevention of pediatric diabetes. Within its network, specialized care is offered for children and adolescents affected by type 1 and type 2 diabetes, genetic obesity, and rare metabolic and autoimmune conditions. 

Advanced screening programs, conducted in collaboration with international research consortia, focus on identifying early markers of type 1 diabetes risk. This allows for timely monitoring, early diagnosis, and the prevention of complications, such as diabetic ketoacidosis. 

Research plays a pivotal role, with ongoing studies exploring the prevention of type 1 diabetes, autoimmune endocrine diseases, and innovative treatments for thyroid disorders and malabsorption syndromes like celiac disease. Physicians also address nutritional and metabolic disorders while working on strategies to prevent osteoporosis in children and adolescents. 

By combining clinical excellence with cutting-edge research, Gruppo San Donato ensures that young patients and their families receive comprehensive, personalized care to improve outcomes and enhance their quality of life.